Scale-Up and Capacity Enhancement of Suspension Cultured Foot-and-Mouth Disease Virus Inactivation Process
With the ongoing threat of foot-and-mouth disease to global livestock,the research and development of the suspension-cultured foot-and-mouth disease virus inactivation process have increasingly become a focal point.This paper aims to systematically explore key issues related to the scale-up of production and the enhancement of capacity in this process to meet the growing demand for foot-and-mouth disease vaccines.In-depth analysis of critical factors such as the optimization of raw material supply chains,equipment,and process flows is conducted.Special attention is given to the application of novel suspension culture techniques,advanced inactivation processes,and automation in production.Emphasis is placed on the importance of safety and regulatory compliance to ensure the reliability and safety of vaccine production.From an economic perspective,a comprehensive assessment of production costs and economic benefits is undertaken to provide decision-makers with a scientific basis.Finally,a profound analysis of current technological and market challenges is presented,along with strategic recommendations for future development.The objective is to drive the sustainable development of the suspension-cultured foot-and-mouth disease virus inactivation process,offering more effective tools and strategic support for foot-and-mouth disease prevention and control.
suspension culturefoot and mouth disease virusinactivation